Plain-English translation of NCT07653984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study designed to help doctors better understand how rare nerve and immune diseases—such as neuromyelitis optica, multiple sclerosis, autoimmune encephalitis, myasthenia gravis, Guillain-Barré syndrome, and MOGAD—affect women who are planning to become pregnant or are already pregnant. Researchers will collect detailed information about your symptoms, treatments, blood work, and brain imaging over five years (and potentially up to ten years) to learn how these conditions change during pregnancy and after delivery.
These rare nerve and immune diseases are more common in women of childbearing age, and they can affect fertility and pregnancy outcomes. Doctors need more detailed information about how best to manage these conditions safely during pregnancy to protect both mother and baby.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be followed for up to five years as you plan for and potentially go through pregnancy. During this time, the research team will collect information about your symptoms, any disease flare-ups, blood tests, brain imaging results, and the medications you take. After you deliver, researchers will continue monitoring your health and your baby's development to see how the disease changes after pregnancy. The study compares your health journey to that of healthy women planning pregnancy to better understand the specific effects of these nerve diseases.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China